>
产品中心 >
Functional_antibody >
BioXcell/InVivoMAb anti-mouse Ly6G/Ly6C (Gr-1)/DISCOUNTED ACADEMIC OR NON PROFIT: 50MG/BE0075-A050mg
About InVivoMAb anti-human IL-9
The MH9A4 monoclonal antibody reacts with human IL-9, a pleiotropic cytokine expressed by Th9 cells, Th2 cells, Th17 cells, regulatory T cells, NKT cells, ILC2s, and mast cells. IL-9 promotes mast cell and T cell proliferation, stimulates mast cell accumulation in tissues, promotes ILC survival, enhances class-switching to IgE in B cells and alters haematopoietic progenitor cell activity. Additionally, IL-9 enhances mucus production from airway epithelial cells and alters barrier function in the intestines. IL-9 is thought to contribute to asthma. The MH9A4 antibody does not block the binding of IL-9 to the IL-9 receptor.
InVivoMAb anti-human IL-9 Specifications
| Isotype | Mouse IgG2b, κ |
| Recommended Isotype Control(s) | InVivoMAb mouse IgG2b isotype control, unknown specificity(BE0086) |
| Recommended InVivoPure Dilution Buffer | InVivoPure pH 7.0 Dilution Buffer(IP0070) |
| Immunogen | Human IL-9 coupled to ovalbumin |
| Reported Applications |
|
| Formulation |
|
| Endotoxin |
|
| Purity |
|
| Sterility | 0.2 μM filtered |
| Production | Purified from tissue culture supernatant in an animal free facility |
| Purification | Protein A |
| Molecular Weight | 150 kDa |
| RRID | AB_2819054 |
| Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
